Structure Therapeutics, Inc. Share Price: GPCR (Structure Therapeutics, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Structure Therapeutics, Inc. share price today?

Accepted Answer

Structure Therapeutics, Inc. (GPCR) share price today is {{live_price}}.

Question 2

Can Indians buy Structure Therapeutics, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Structure Therapeutics, Inc. (GPCR) from India.

With INDmoney, you can buy Structure Therapeutics, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Structure Therapeutics, Inc. at zero transaction cost.

Question 3

How can I buy Structure Therapeutics, Inc. shares from India?

Accepted Answer

It is very easy to buy Structure Therapeutics, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Structure Therapeutics, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Structure Therapeutics, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Structure Therapeutics, Inc. stocks?

Accepted Answer

To start investing in Structure Therapeutics, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Structure Therapeutics, Inc.

Accepted Answer

Today’s highest price of Structure Therapeutics, Inc. (GPCR) is {{1_rba_end}}.

Today’s lowest price of Structure Therapeutics, Inc. (GPCR) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Structure Therapeutics, Inc.

Accepted Answer

Today's market capitalisation of Structure Therapeutics, Inc. GPCR is 1.9B

Question 8

What is the 52 Week High and Low Range of Structure Therapeutics, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Structure Therapeutics, Inc. is down from its 52 Week High?

Accepted Answer

Structure Therapeutics, Inc. (GPCR) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Structure Therapeutics, Inc. is up from its 52 Week low?

Accepted Answer

Structure Therapeutics, Inc. (GPCR) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Structure Therapeutics, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Structure Therapeutics, Inc.

Accepted Answer

Dr. Raymond C. Stevens Ph.D. is the current Chief Executive Officer (CEO) of Structure Therapeutics, Inc..

Period	Structure Therapeutics, Inc.	Index (Russel 2000)
3 Months	25.18%	0.0%
6 Months	-17.81%	0.0%
1 Year	66.42%	0.0%
3 Years	102.85%	-22.6%

Market Capitalization	1.9B
Book Value	$9.22
Earnings Per Share (EPS)	-2.25
Wall Street Target Price	76.89

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-20.43%
Return On Equity TTM	-29.33%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-114.7M
Diluted Eps TTM	-2.25
Quarterly Earnings Growth YOY	0.0

Structure Therapeutics, Inc. (GPCR)

Vs NVO

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.88
EPS Estimate Next Year	-1.01
EPS Estimate Current Quarter	-0.21
EPS Estimate Next Quarter	0.0

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Structure Therapeutics, Inc.	32.71%	-17.81%	66.42%	102.85%	102.85%
Moderna, Inc.	21.03%	85.08%	14.68%	-28.27%	659.22%
Regeneron Pharmaceuticals, Inc.	3.22%	20.18%	31.88%	93.3%	227.58%
Novo Nordisk A/s	8.85%	34.38%	71.83%	235.07%	463.44%
Vertex Pharmaceuticals Incorporated	16.81%	34.1%	40.6%	123.97%	174.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Structure Therapeutics, Inc.	NA	NA	NA	-0.88	-0.29	-0.2	NA	9.22
Moderna, Inc.	24.73	NA	0.0	-7.14	-0.38	-0.16	NA	33.47
Regeneron Pharmaceuticals, Inc.	28.89	28.89	1.46	44.13	0.15	0.08	NA	250.15
Novo Nordisk A/s	46.97	46.97	2.36	3.5	1.0	0.25	0.01	22.18
Vertex Pharmaceuticals Incorporated	29.59	29.59	0.53	17.08	0.24	0.13	NA	71.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Structure Therapeutics, Inc.	Buy	$1.9B	102.85%	NA	0.0%
Moderna, Inc.	Buy	$54.6B	659.22%	24.73	-115.82%
Regeneron Pharmaceuticals, Inc.	Buy	$108.0B	227.58%	28.89	29.45%
Novo Nordisk A/s	Buy	$602.6B	463.44%	46.97	36.55%
Vertex Pharmaceuticals Incorporated	Buy	$117.5B	174.53%	29.59	39.46%

Organization	Structure Therapeutics, Inc.
Employees	93
CEO	Dr. Raymond C. Stevens Ph.D.
Industry	Healthcare